This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
The COMBINE-AF Trial | MicrobiomeTrials
← Back to trials NCT07633509
The COMBINE-AF Trial Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-27Est. Completion: 2028-12-31
Enrollment target: 430 participantsLocations Fuwai Hospital, Beijing, Beijing Municipality, China Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing Municipality, China Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University , Jiangsu Women and Children Health Hospital）, Nanjing, Jiangsu, China Other microbiome trials you might be interested in Paroxysmal Atrial Fibrillation (PAF) Persistent Atrial Fibrillation
The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely a…
Jonesboro, United States Est. completion Jul 20, 2028
Persistent Atrial Fibrillation
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation…
Birmingham, United States Est. completion Feb 4, 2026